(Q28257651)

12 December 2020

Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naı̈ve healthy male volunteers under a naltrexone block

1 reference

12 December 2020

Relative bioavailability of different buprenorphine formulations under chronic dosing conditions

1 reference

12 December 2020

Use of buprenorphine in pregnancy: patient management and effects on the neonate

1 reference

12 December 2020

Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine

1 reference

12 December 2020

Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases

1 reference

12 December 2020

A review of developmental aspects of cytochrome P450.

1 reference

12 December 2020

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

1 reference

12 December 2020

Buprenorphine TDS: the clinical development rationale and results.

1 reference

12 December 2020

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

1 reference

12 December 2020

Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents

1 reference

12 December 2020

Six deaths linked to concomitant use of buprenorphine and benzodiazepines

1 reference

12 December 2020

Intraoperative estimation of liver blood flow in man

1 reference

12 December 2020

Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth

1 reference

12 December 2020

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

1 reference

12 December 2020

Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine

1 reference

12 December 2020

Fatal intoxication following self-administration of a massive dose of buprenorphine

1 reference

12 December 2020

A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence

1 reference

12 December 2020

Buprenorphine and naloxone interactions in methadone maintenance patients

1 reference

12 December 2020

Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study

1 reference

12 December 2020

Lack of Interaction of Buprenorphine With Flunitrazepam Metabolism

1 reference

12 December 2020

A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies

1 reference

12 December 2020

Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine

1 reference

12 December 2020

Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens

1 reference

12 December 2020

Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality

1 reference

12 December 2020

Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients.

1 reference

12 December 2020

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

1 reference

12 December 2020

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

1 reference

12 December 2020

Deaths involving buprenorphine: a compendium of French cases

1 reference

12 December 2020

Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.

1 reference

12 December 2020

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

1 reference

12 December 2020

Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease

1 reference

12 December 2020

Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine

1 reference

12 December 2020

Double-blind randomized trial of buprenorphine and methadone in opiate dependence

1 reference

12 December 2020

Sublingual absorption of selected opioid analgesics

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes

1 reference

12 December 2020

Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

1 reference

12 December 2020

Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors

1 reference

12 December 2020

The metabolism and excretion of buprenorphine in humans

1 reference

12 December 2020

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

1 reference

12 December 2020

Buprenorphine kinetics

1 reference

12 December 2020

Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans

1 reference

12 December 2020

Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis

1 reference

12 December 2020

Bioavailability of sublingual buprenorphine

1 reference

12 December 2020

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

12 December 2020

Buprenorphine withdrawal syndrome in a newborn

1 reference

12 December 2020

Splanchnic circulation during halothane anesthesia and hypercapnia in normal man.

1 reference

12 December 2020

Buprenorphine: new pharmacological aspects.

1 reference

12 December 2020

Permeation of buprenorphine and its 3-alkyl-ester prodrugs through human skin

1 reference

12 December 2020

Biliary excretion, metabolism and enterohepatic circulation of buprenorphine

1 reference

12 December 2020

Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes

1 reference

12 December 2020

Sex-specific determinants of HIV infection among injection drug users in Montreal

1 reference

12 December 2020

Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: Comparison of those who do and do not experience withdrawal and concentration-effect relationships

1 reference

12 December 2020

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

12 December 2020

The estimated prevalence and incidence of HIV in 96 large US metropolitan areas

1 reference

12 December 2020

Buprenorphine in end stage renal failure.

1 reference

12 December 2020

Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine

1 reference

12 December 2020

HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme

1 reference

12 December 2020

Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers

1 reference

12 December 2020

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.

1 reference

12 December 2020

Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling

1 reference

12 December 2020

Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet

1 reference

12 December 2020

Buprenorphine alone and in combination with naloxone in non-dependent humans.

1 reference

12 December 2020

Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphine.

1 reference

12 December 2020

Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference.

1 reference

12 December 2020

Buprenorphine and naloxone alone and in combination in opioid-dependent humans

1 reference

12 December 2020

Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations

1 reference

12 December 2020

Effects of sublingually given naloxone in opioid-dependent human volunteers

1 reference

12 December 2020

Effect of buprenorphine on CYP3A activity in rat and human liver microsomes

1 reference

12 December 2020

Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4.

1 reference

12 December 2020

Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry

1 reference

12 December 2020

Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities

1 reference

12 December 2020

The radioimmunoassay of buprenorphine

1 reference

12 December 2020

Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites

1 reference

12 December 2020

Deaths attributable to methadone vs buprenorphine in France

1 reference

12 December 2020

Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis

1 reference

12 December 2020

Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4.

1 reference

12 December 2020

Effects of buprenorphine/naloxone in opioid-dependent humans

1 reference

12 December 2020

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine

1 reference

12 December 2020

Inhibition of human drug metabolizing cytochrome P450 by buprenorphine

1 reference

12 December 2020